Menotropins

CHEMBL2108427 Phase 4 Approved Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A mixture of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) extracted from the urine of postmenopausal women, used in fertility treatments to stimulate egg development and ovulation. It is given by injection as part of assisted reproductive technology procedures.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A mixture of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) extracted from the urine of postmenopausal women, used in fertility treatments to stimulate egg development and ovulation. It is given by injection as part of assisted reproductive technology procedures.

Yes, Menotropins is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108427. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Looking for patient-friendly information?

Menotropins on PillFYI

Quick Data

Synonyms: 1

External Links

ChEMBL CHEMBL2108427

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.